ORIGENE

You can reach the ORIGENE website Here

OriGene Technologies, represented by ALFAGEN, was established as a research company focused on the generation of large commercial collections of full length human cDNAs in a standard expression vector. The availability of the whole human genome sequence and subsequent development of genome-based tools has enabled the identification of drug targets relevant to systems biology approaches. OriGene’s vision is to develop comprehensive, genome-wide research tools and technology platforms to enable scientists to study all biological pathways, thereby providing a better understanding of disease mechanisms, including cancer and stem cell research.

  • cDNA Clones
  • Antibodies
  • Proteins vectors
  • RNAi
  • Genome Editing assay kits ,

 You can get detailed information about the products from ALFAGEN representatives and via Link

 

OriGene Technologies uses a high-throughput, genome-wide approach to develop products for pharmaceutical, biotechnology, and academic research. Our flagship cDNA clone collection is a searchable gene bank of over 30,000 human full-length TrueClone cDNA collections and over 25,000 TrueORF cDNA clones. From our TrueORF cDNA clones, we have developed a wide range of full-length human proteins expressed in mammalian cells and idealized for functional studies. In 2010 OriGene launched the TrueMAB ™ project to develop mouse monoclonal antibodies against protein antigens to develop protein assays for each human protein.

In addition, OriGene offers different gene expression products such as TissueScan cancer tissue qPCR arrays, tissue biological repositories for biomarker discovery and validation. Under the umbrella of ALFAGEN, it aims to be the biggest supporter of researchers in the Turkish market.

ALFAGEN and OriGene are firmly committed to their mission to be “Your Gene Company” and to provide everything a researcher needs for gene-based research.

You can reach the relevant documentation and information via the link